The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Sorry, wandering!
He's having a laugh unless he's spotted LC wondering into company or ministry offices in Tanz, Moz or Bots! But we'll keep an open mind....
I realise talk seems to have moved on from this now but Afrimin Resources Limited was 'only' Incorporated on 2021-02-22.
Make of that what you will....
https://portal.pacra.org.zm/search#here
Here's another:
https://www.globalpsoriasisatlas.org/
Here's another:
https://www.globalpsoriasisatlas.org/
Mathurin - if think that was a wild guess based on research from Manchester Uni (1.1 million Ps sufferers in the UK):
https://www.manchester.ac.uk/discover/news/new-figures-show-psoriasis-affects-around-11-million-people-in-uk/
I'm scratching around trying to find any indication that there may be any progress whatsoever at either MAST / MED or KIBO seeing as our CEO / BoD has gone silent. Had to resort to Twitter -urgh! Posted on 23rd March on the MAST feed is a quote from Alok Sharma, “...Meanwhile, solar and wind power are growing faster than ever. Coal power is on its way out. Clean power is the future...”
OK, if this is the case and MAST are insistent on quoting it, why is the current parent company, KIBO, still trying to get three coal to power projects going in Africa?!! I have said before that KIBO perhaps needs to rethink its strategy in light of the way the west is heading as regards to coal but doesn't using this quotation shoot the company in the foot with its existing projects? I can also understand why MED is busy promoting green energy but at least do it after KIBO has released MED into the wild and set it free along its 'green' road!
The continuing lack of news on MED, and the projects in Tanzania, Botswana and Mozambique is just pitiful really, especially as shareholders are continually strung along with tales of how things will happen in 'the coming weeks' . Our CEO cannot continue to blame delays on everything as covid-related either.
Once upon a time (20/09/2016) this share hit 9.25p. If you look at the 5 year chart, it's basically flat-lined for over two years! Our CEO and BoD urgently need to get these projects going and the electricity flowing to bump start the beast back to life!
That Twitter post looks like a communication to AAL to get more serious about their offer!
Apologies, somebody else mentioned the content of this but here's the link...
https://www.share-talk.com/share-talk-bulletin-board-heroes-tuesday-16th-march-2021/#gs.vty92l
You couldn't trade KIBO for a good part of yesterday because they were migrating the shares as per the RNS of 9/03/2021.
All seems good to go today so you need to speak to your trading platform.
Even funnier to see the comment by "sewingmachine" on the AAL discussion board on the 5th March!
Thanks Aerial, I knew there was a US$900 million debt facility in one of the RNS's! So funding is there for Moz if they chose to go down the mine operator route...
Well we already paid a surcharge for purchasing non-UK listed shares when we bought Irish listed company shares so maybe in fact it won't make that much difference on the buying side but I got the impression its on the sale side too.
I guess we'll find out when selling when Kibo reaches 2p!!
I have to admit though I'm beginning to wonder what's happening with MED and LC's listing. It feels like he's true to form and not getting this across the line either. Roll on next week....
Yes! I had the same message on EQI. Sadly they'll incurr extra charges buying and selling. Those fees were in the email too, depending on the value of your holding or purchase. Another consequence of Brexit unfortunately.
Belgrano - taking your article further, if 'only' the lowest number of 4.5 million Americans who have psoriasis spent $20 per month each month on the AxisBiotix product (I'm just guessing a monthly purchase price here and assuming it produces similar results to prescription medicines mentioned in the article) then that's 'automatically' an annual turnover of well over US$ 1 billion....
I'm not sure why anyone would want to be selling right now!
True too! Totally agree about the reduction of risk with AA's involvement. That's probably actually the key point.
I'm not sure why they'd want to be selling either. Another 18 - 24 months and the company potentially could be generating cash so hence paying for its own exploration - and with no intended / planned dilution until 2022, allegedly!
Agree, currently 6 MMs holding this back at 6p!
Sorry but the company does have a 'product' - its IP - Intellectual Property. The original research was ground breaking and the science is proving itself. The products which might eventually develop from that IP can only add further to the company's value.